BioSpace News Archive

Business

ResMed Elects Karen Drexler to its Board of Directors

ResMed today announced it has elected accomplished healthcare executive Karen Drexler to its Board of Directors.

November 17, 2017

·

3 min read

Business

BerGenBio ASA: Results for the Third Quarter 2017

A presentation of the results by the Company’s senior management team will take place today at 9.00 am CET in Oslo -details below.

November 17, 2017

·

3 min read

Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE Micro-Sensor for Improved Monitoring of Glaucoma Patients

Implandata now reports that its optimized next generation EYEMATE micro-sensor implant for intraocular placement has successfully passed first-in-human validation.

November 17, 2017

·

3 min read

Digital Medicine Changemakers Are Center Stage at CNS Summit 2017: Otsuka and Proteus, Akili Interactive Labs, and Pear Therapeutics to Receive CNS Summit 2017 Innovation Awards

CNS Summit, a community at the intersection of life sciences and technology, will bring together key figures leading the digital transformation of the life science industry.

November 17, 2017

·

1 min read

Policy

Statement by FDA Commissioner Scott Gottlieb, M.D., on Efforts to Address Impact of IV Fluid Shortages Following Hurricane Destruction and Resolve Manufacturing Shortfalls

It’s been nine weeks since Hurricane Maria made landfall on Puerto Rico and the island continues to struggle to recover from the devastation brought by this storm, as well as Hurricane Irma.

November 17, 2017

·

5 min read

VBL Therapeutics Prices 2.5 Million Ordinary Share Offering

The offering is subject to customary closing conditions and is expected to close on or about November 21, 2017.

November 17, 2017

·

4 min read

Policy

Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA

The company wishes to clarify the observations from the two trials previously reported and its plans to include the data in an application for marketing authorization by FDA.

November 17, 2017

·

11 min read

Business

Vilacto Bio Inc. Retains Established Independent Investor Relations Firm, The Equity Group Inc.

Vilacto Bio selected The Equity Group due to its 43-year track record of delivering specialized, comprehensive IR programs for small- and mid-sized public companies.

November 17, 2017

·

2 min read

Business

International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

Combined operating income for the nine months ended September 30, 2017 from our two wholly owned revenue-generating subsidiaries was $1.3 million, an increase of 30% compared to $1.0 million in the same period in 2016.

November 17, 2017

·

7 min read

Drug Development

Celldex Therapeutics Initiates Phase II Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma

The study will enroll approximately 30 patients with cetuximab-resistant, advanced HNSCC who have previously been treated with an anti-PD1 checkpoint inhibitor.

November 17, 2017

·

6 min read